Quark Pharmaceuticals

Quark Pharmaceuticals, Inc.
Industry Health Care
Founded 1993
Headquarters Fremont, California, United States,
Nes Ziona, Israel
Key people
Philip B. Simon, Chairman
Daniel Zurr, CEO
Rami Skaliter, COO
Number of employees
+70 (2006)
Website www.quarkpharma.com

Quark Pharmaceuticals is a pharmaceutical company that develops RNA interference-based treatments for chronic and acute diseases.[1] The company uses state of the art RNA interference technology to develop siRNAs, which inhibit targeted genes from producing proteins associated with certain diseases.

Two products are reported to be in Phase III clinical trials: QPI-1002 for delayed graft function [2] and QPI-1007 for Acute Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION).[3]

History Highlights


This article is issued from Wikipedia - version of the 11/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.